Journey Medical (DERM) Short term Debt (2021 - 2026)

Journey Medical's Short term Debt history runs 5 years deep, the most recent figure standing at $2.5 million for Q1 2026.

• Quarterly Short term Debt rose 33.33% year-over-year to $2.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 million (up 33.33% YoY) and the FY2022 annual result came in at $2.9 million, up 263.05% from the prior year.
• Short term Debt was $2.5 million for Q1 2026 at Journey Medical, down from $5.6 million in the prior quarter.
• Across five years, Short term Debt topped out at $9.9 million in Q2 2023 and bottomed at $1.9 million in Q1 2025.
• A 4-year average of $5.2 million and a median of $3.8 million in 2025 frame the typical range for Short term Debt.
• Annual changes were most pronounced in 2022 — Short term Debt soared 263.05% — and 2026, when it jumped 33.33%.
• Journey Medical's Short term Debt stood at $2.9 million in 2022, then soared by 237.25% to $9.9 million in 2023, then plunged by 43.42% to $5.6 million in 2025, then plunged by 55.56% to $2.5 million in 2026.
• Business Quant data shows DERM's Short term Debt at $2.5 million in Q1 2026, $5.6 million in Q3 2025, and $3.8 million in Q2 2025.